Schonfeld Strategic Advisors LLC Novo Cure LTD Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 101,140 shares of NVCR stock, worth $1.63 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

101,140

Previous 363,777 72.2%

Holding current value

$1.63 Million

Previous $5.69 Million 69.53%

% of portfolio

0.01%

Previous 0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $3.11 Million - $6.32 Million	-262,637 Reduced 72.2%	101,140 $1.73 Million
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $3.56 Million - $4.96 Million	287,014 Added 373.9%	363,777 $5.69 Million
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $312,897 - $443,623	28,113 Added 57.79%	76,763 $1.15 Million
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $785,697 - $2.06 Million	48,650 New	48,650 $785,000
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $21,881 - $29,196	342 New	342 $25,000
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $639,580 - $1.02 Million	-11,300 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $679,695 - $955,076	11,300 New	11,300 $936,000
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $136,044 - $221,045	-1,812 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$116.17 - $194.55 $210,500 - $352,524	1,812 New	1,812 $211,000
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $593,999 - $922,245	-5,296 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$58.05 - $111.31 $307,432 - $589,497	5,296 New	5,296 $589,000
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $839,352 - $1.09 Million	-14,674 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $837,151 - $1.41 Million	14,674 New	14,674 $988,000
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $1.03 Million - $1.42 Million	-15,097 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $933,900 - $1.48 Million	15,097 New	15,097 $1.13 Million

Others Institutions Holding NVCR

# of Institutions

267

Shares Held

77.1M

Call Options Held

751K

Put Options Held

293K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.69B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Novo Cure LTD Transaction History